Ming Zhao
- Biotechnology top 0.02%
- Biomedical Engineering top 0.5%
- Genetics top 0.5%
- Oncology top 2%
- Hepatology top 0.5%
- Co-authors
- Robert M. HoffmanMichael BouvetMeng YangYong ZhangSheldon PenmanHuaiyu MaShukuan LiPeihong Wu
- Topics
- Cancer Research and Treatments (88 papers)Nanoplatforms for cancer theranostics (69 papers)Virus-based gene therapy research (60 papers)
- Cited by
- BiotechnologyHepatologyGenetics
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- United StatesChinaJapan
In The Last Decade
Ming Zhao
192 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Biotechnology 3.4k
- Biomedical Engineering 2.9k
- Genetics 2.1k
- Oncology 1.4k
- Hepatology 1.3k
Countries citing papers authored by Ming Zhao
This map shows the geographic impact of Ming Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhao more than expected).
Fields of papers citing papers by Ming Zhao
This network shows the impact of papers produced by Ming Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhao. The network helps show where Ming Zhao may publish in the future.
Co-authorship network of co-authors of Ming Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhao. A scholar is included among the top collaborators of Ming Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhao. Ming Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 26 | |
| 7 | 6 | |
| 8 | 17 | |
| 9 | 16 | |
| 10 | 34 | |
| 11 | 15 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 65 | |
| 15 | 42 | |
| 16 | 36 | |
| 17 | 119 | |
| 18 | 1 | |
| 19 | 65 | |
| 20 | Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment. | 34 |
About Ming Zhao
Ming Zhao is a scholar working on Biotechnology, Hepatology and Genetics, having authored 199 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Research and Treatments (88 papers), Nanoplatforms for cancer theranostics (69 papers) and Virus-based gene therapy research (60 papers). The work is most often cited by research in Biotechnology (3.4k citations), Hepatology (1.3k citations) and Genetics (2.1k citations). Ming Zhao has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Robert M. Hoffman, Michael Bouvet, Meng Yang, Yong Zhang, Sheldon Penman, Huaiyu Ma, Shukuan Li, Peihong Wu, Xiaoming Li and Ning Lyu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.